Alendronic acid/colecalciferol - Osteoporosis
You are here : Home > Formulary Search > Alendronic acid/colecalciferol - Osteoporosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (Local)
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Alendronic acid/colecalciferol
Indication :
Osteoporosis
Group Name :
Keywords :
bisphosphonate
Brand Names Include :
Fosavance
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Other Indications
Below are listed other indications that Alendronic acid/colecalciferol is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Osteoporosis.
Committee Recommendations (1)
An evidence review of Fosavance, Bonviva and Protelos in the treatment of postmenopausal osteoporosis was conducted. The evidence for Fosavance is limited and is therefore not supported by the APC. NICE guidance recommends alendronate as the bisphophonate of first choice.